Patent · US Active

1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors

US7928238B2 · kind B2 · utility

7Cited by

12References

57Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Thomas A. Rano · Somerville, US
Gee-Hong Kuo · Scotch Plains, US
Ellen Sieber-McMaster · Langhorne, US
Keith Demarest · Flemington, US
Patricia Pelton · Long Valley, US
Aihua Wang · Jamison, US

Key dates

Filing date	May 10, 2007
Grant date	Apr 19, 2011
Priority date	—
Expiry date	Apr 9, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is directed to compounds of Formula (I) described herein useful as CETP inhibitors, compositions containing them, and methods of using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.